GenoFocus Inc Cash Flow Reinvestment Rate

Latest as of December 2025: 7.15x

GenoFocus Inc cash flow reinvestment rate. GenoFocus Inc (187420) has a Cash Flow Reinvestment Rate of 7.15x as of December 2025, reinvesting ₩2.06 Billion (capex ₩138.88 Million plus investments ₩-1.92 Billion) from operating cash flow of ₩288.09 Million. See 187420 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.

Reinvestment Rate

7.15x
(Capex + Investments) / Operating CF

Total Reinvested

₩2.06 Billion
Capex + Investments

Operating Cash Flow

₩288.09 Million
KRW

Capital Expenditures

₩138.88 Million
KRW

Cash Flow Reinvestment Rate of GenoFocus Inc (2015–2025)

Cash flow reinvestment rate of GenoFocus Inc from 2015 to 2025. Historical reinvestment intensity for GenoFocus Inc across 6 annual periods. Explore GenoFocus Inc debt service capacity to assess how comfortably operating cash covers total debt obligations.

GenoFocus Inc Cash Flow Reinvestment Rate by Year (2015–2025)

GenoFocus Inc cash flow reinvestment rate by year from 2015 to 2025. Year-by-year capital reinvestment analysis for GenoFocus Inc. For the full cash flow conversion analysis, see GenoFocus Inc cash conversion from operations.

Year Reinvestment Rate Total Reinvested (KRW) Operating CF Capex YoY Change
2025 2.28x ₩8.00 Billion ₩3.50 Billion ₩1.08 Billion ▼ -8.4%
2024 2.49x ₩7.15 Billion ₩2.87 Billion ₩699.16 Million ▼ -75.3%
2018 10.10x ₩15.80 Billion ₩1.56 Billion ₩7.42 Billion ▼ -4.5%
2017 10.58x ₩14.43 Billion ₩1.36 Billion ₩2.06 Billion ▼ -85.6%
2016 73.60x ₩37.98 Billion ₩516.09 Million ₩5.46 Billion ▲ +2249.8%
2015 3.13x ₩8.94 Billion ₩2.85 Billion ₩8.14 Billion —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow